HEMOTAG® Assessment for Short-term Outcomes of Heart Failure

This study is evaluating a wearable device called HEMOTAG to monitor patients with heart failure after they leave the hospital. The device tracks fluid levels and other markers to help predict whether a patient might need to return to the hospital. The goal is to see if remote monitoring can help doctors intervene earlier and prevent readmissions. **You may be eligible if...** - You are 22 years or older - You have been admitted to the hospital for acute decompensated heart failure (your heart is not pumping well and you have fluid buildup) - You are receiving IV diuretics or blood pressure medications - Your BNP or NT-proBNP levels are elevated (indicating heart strain) - You have cellular data coverage at home - If you have a history of reduced heart function, you must have been on standard heart failure medications for at least 90 days **You may NOT be eligible if...** - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.